A simplified score to quantify comorbidity in COPD

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Putcha, Nirupama ^a   Puhan, Milo A ^b   Drummond, M Bradley ^b   Han, MeiLan K ^c   Regan, Elizabeth A ^d   Hanania, Nicola A ^e   Martinez, Carlos H ^c   Foreman, Marilyn ^f   Bhatt, Surya P ^g   Make, Barry ^d   Ramsdell, Joe ^h   DeMeo, Dawn L ⁱ   Barr, R Graham ^j   Rennard, Stephen I ^k   Martinez, Fernando ^l   Silverman, Edwin K ⁱ   Crapo, James ^d   Wise, Robert A ^a   Hansel, Nadia N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MICHIGAN   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f MOREHOUSE SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Department of Medicine   (United States)

^k UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^l WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE EXACERBATION; EXTERNAL VALIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCORE; OXYGEN THERAPY; PREDICTION; QUALITY OF LIFE; RISK FACTOR; SCORING SYSTEM; SIX MINUTE WALK DISTANCE; SMOKING HABIT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; VERY ELDERLY; AREA UNDER THE CURVE; COST OF ILLNESS; HEALTH STATUS INDICATOR; OUTCOME ASSESSMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE;

AREA UNDER CURVE; COMORBIDITY; COST OF ILLNESS; HEALTH STATUS INDICATORS; HUMANS; PATIENT OUTCOME ASSESSMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84918561673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114438     Document Type: Article

References (31)

1. Kochanek KD, Xu JQ, Murphy SL, Minino AM, Kung HC (2011) Deaths: Preliminary data for 2009. National vital statistics reports 59(4): 1-51.
2. Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, et al. (2012) The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 12: 26.
3. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, et al BODE Collaborative Group. (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(2): 155-161.
4. Holguin F, Folch E, Redd SC, Mannino DM (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128(4): 2005-2011.
5. van Manen JG, Bindels PJ, Dekker EW, Ijzermans CJ, Bottema BJ, et al. (2001) Added value of comorbidity in predicting health-related quality of life in COPD patients. Respir Med 95: 496-504.
6. Wijnhoven HA, Kriegsman DM, Hesselink AE, de Haan M, Schellevis FG (2003) The influence of comorbidity on health-related quality of life in asthma and COPD patients. Respir Med 97(5): 468-475.
7. Yeo J, Karimova G, Bansal S (2006) Co-morbidity in older patients with COPD-its impact on health service utilisation and quality of life, a community study. Age Ageing 35(1): 33-37.
8. Putcha N, Puhan MA, Hansel NN, Drummond MB, Boyd CM (2013) Impact of co-morbidities on selfrated health in self-reported COPD: An analysis of NHANES 2001-2008. COPD 10(3): 324-332
9. St Germaine-Smith C, Liu M, Quan H, Wiebe S, Jette N (2011) Development of an epilepsy-specific risk adjustment comorbidity index. Epilepsia 52(12): 2161-2167.
10. Della Porta MG, Malcovati L, Strupp C, Ambaglio I, Kuendgen A, et al. (2011) Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome. Haematologica 96(3): 441-449.
11. Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, et al. (2007) Hematopoietic cell transplantation specific comorbidity index as an outcome predict9or for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110(13): 4606-4613.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5): 373-383.
13. Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, et al. (2014) Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol 67(8): 904-911.
14. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, et al. (2010)Genetic epidemiology of COPD (COPDGene) study design. COPD 7(1): 32-43.
15. Couper D, Lavange LM, Han M, Barr RG, Bleecker E, et al. for the SPIROMICS Research Group. (2014) Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 69(5): 491-494.
16. van den Akker M, Buntinx F, Metsemakers JFM, Roos S, Knottnerus JA (1998) Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent Diseases. J Clin Epidemiol 51(5): 367-375.
17. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, et al. (2000) American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 22(9): 1121-1145.
18. Schünemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, et al. (2003) Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 56(12): 1170-1176.
19. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM (1982) Two, six, and 12 minute walking tests in respiratory disease. B.M.J. 284: 1607-1608.
20. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, et al. (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581-586.
21. Cleves MA (2002) From the help desk: Comparing areas under receiver operating characteristic curves from two or more probit or logit models. The Stata Journal 2 (3): 301-313.
22. StataCorp (2011) Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
23. Baker SG, Schuit E, Steyerberg EW, Pencina MJ, Vikers A, et al. (2014) How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through. Stat Med 33(22): 3946-3959.
24. Oksanen T, Kivimäki M, Pentti J, Virtanen M, Klaukka T, et al. (2010) Self-report as an indicator of incident disease. Ann Epidemiol 20(7): 547-554.
25. Midthjell K, Holmen J, Bjørndal A, Lund-Larsen G (1992) Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study. J Epidemiol Community Health 46(5): 537-542.
26. Beckett M, Weinstein M, Goldman N, Yu-Hsuan L (2000) Do health interview surveys yield reliable data on chronic illness among older respondents? Am J Epidemiol 151(3): 315-323.
27. Paganini-Hill A, Chao A (1993) Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol 138(2): 101-106.
28. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, et al. (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5): 894-900.
29. Desai MM, Bruce ML, Desai RA, Druss BG (2001) Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol 153(3): 299-306.
30. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM (1982) Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 142: 1470-1476.
31. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, et al. (2013) Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(7): 728-735.